2014年9月19日（星期五）下午

Friday Afternoon, Sept. 19th, 2014

全体大会(Plenary)    全部视频回看

地点(Venue): 厦门国际会议中心2楼海峡厅

            Straits Meeting Hall, 2nd Floor, Xiamen International Conference Center

荣誉主席(Honorary President)：

吴孟超 院士 Meng-Chao Wu   孙  燕 院士 Yan Sun 

廖美琳 Mei-Lin Liao     管忠震 Zhong-Zhen Guan

大会主席(Conference President)：

吴一龙 Yi-long Wu   秦叔逵 Shu-Kui Qin   马  军 Jun Ma

主    持(Moderators)：

李  进 Jin Li   王绿化 Lv-Hua Wang

14:30~14:40 主席致词(President's Address) 孙燕 院士 Yan Sun     视频回看

14:40~14:50 主席致词(President's Address) 吴一龙 Yi-long Wu     视频回看

颁奖典礼(Awarding Ceremony and Lecture) 

14:50~14:55  终身成就奖颁奖嘉宾(Life Achievement Award Presenters)

            廖美琳 Mei-Lin Liao   管忠震 Zhong-Zhen Guan

14:55~15:10  终身成就奖获奖感言(Acceptance Speech of Life Achievement Award)

15:10~15:15  年度成就奖颁奖嘉宾

            (Annual Cooperation Award & Annual Achievement Award Presenters)

            孙  燕 院士 Yan Sun   马  军 Jun Ma

15:15~15:30  年度成就奖获奖演讲(Acceptance Speech of Annual Achievement Award)

15:30~15:35  CSCO—默克雪兰诺肿瘤研究基金成立   视频回看

            默克雪兰诺中国研发中心负责人：郭  峰

主     持(Moderators)：

吴一龙 Yi-long Wu   秦叔逵 Shu-Kui Qin

大会报告(Keynote Speech)

15:35~16:05  Development of Immunotherapy for Lung Cancer    视频回看

            Naiyer A. Rizvi   Memorial Sloan-Kettering Cancer Center, USA

16:05~16:10  Q&A

论文交流(Oral Presentations)

16:10~16:20  Safety and efficacy of the Asian subgroup of patients (pts) with EGFR-TKI- resistant advanced non-small cell lung cancer (NSCLC) in a phase I study of AZD9291 (AURA)                                                                                                                       视频回看

            Myung-Ju Ahn   Sungkyunkwan University, Korea

16:20~16:25  Q&A

16:25~16:40  专家点评(Abstract Discussion)                        视频回看

           Jie Wang 王  洁   北京大学临床肿瘤学院(Beijing Cancer Hospital)

16:40~16:50  Overall survival (OS) with afatinib (A) vs gemcitabine/cisplatin (GC) in treatment- naive Chinese patients (pts) with advanced non-small cell lung cancer (NSCLC) harboring EGFR mutations (mut): subpopulation analysis from LUX-Lung 6 (LL6)      视频回看

            Yi-long Wu 吴一龙   广东省人民医院(Guangdong General Hospital)

16:50~16:55  Q&A

16:55~17:10  专家点评(Abstract Discussion)                         视频回看

            Li Zhang 张  力   中山大学附属肿瘤医院(Sun Yat-sen University Cancer Center)

17:10~17:20  Phase III study of apatinib in advanced gastric cancer: A randomized, double-blind, placebo- controlled trial. 阿帕替尼治疗晚期胃癌的随机、双盲、平行对照、全国多中心III期临床研究                                                                                                                                      视频回看

            Shu-Kui Qin 秦叔逵   南京八一医院 (No. 81 Hospital)

17:20~17:25  Q&A

17:25~17:40  专家点评(Abstract Discussion)                         视频回看

           Jian-Ming Xu 徐建明   军事医学科学院附属医院 (No. 307 Hospital)

17:40~17:50  Efficacy and safety of regorafenib (REG) monotherapy in Chinese patients with previously treated metastatic colorectal cancer (mCRC): Subgroup analysis of the CONCUR trial                                                                                                                                          视频回看

            Rui-Hua Xu 徐瑞华   中山大学附属肿瘤医院 (Sun Yat-sen University Cancer Center)

17:50~17:55  Q&A

17:55~18:10  专家点评(Abstract Discussion)                                                 视频回看

            Lin Shen 沈  琳   北京大学临床肿瘤学院(Beijing Cancer Hospital)